Skip to main content

Search

Study Title Study Sponsor Status Study Drug Trial Phase Study Protocol Number Site
Extending molecular responeses with Nilotinib in newly diagnosed chronic myeloid leukemia (CML) patients in chronic phase (ENESTxtnd) Novartis Completed Nilotinib 3b CAMN107E2401 KFSH
Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC): A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial of MST-188 (Purified Poloxamer 188) Injection in Subjects With Sickle Cell Disease Experiencing Vaso Occlusive Crisis Mast Therapeutics Ongoing Purified Poloxamer 188 3 MST-188-01 KKUH
Escalating Dose and Randomized, Controlled Study of Nusinersen (BIIB058) in Participants With Spinal Muscular Atrophy Biogen Idec Research Limited Ongoing Nusinersen (Spinraza) 3 232SM203 King Fahad Specialist Hospital (Dammam)
Efficacy of Topical Delivery of Vitamin D3: A phase II Study. University of Dammam Rejected vitamin D3 2 IRB-2014-01-157 KFUH
Efficacy Of Single Dose Rituximab and Mycophenolate Versus Two Doses Rituximab in Children with Steroid Dependent and Frequent Relapsing Nephrotic Syndrome: Randomized Open-Labeled Pilot Trial KFSH&RC-J Completed Rituximab / Mycophenolate 2 2020-99 KFSH&RC-J
Efficacy of lntra-cervical Misoprostol in the Management of Early Pregnancy Failure: Randumized Clinical Trial King Abdulaziz University Hospital On Hold Misoprostol 3 227-15 KAUH-J
Efficacy and Safety of Long-Term (6 Months) Innohep® Treatment Versus Anticoagulation With a Vitamin K Antagonist (Warfarin) for the Treatment of Acute Venous Thromboembolism in Cancer Patients Leo Completed Innohep (Tinzaparin) VS. Warfarin 3 IN 0901 INT NGHA-R
Efficacy and Safety of Irbesartan/Amlodipine Fixed Combination Therapy Compared With Irbesartan Monotherapy in Hypertensive Patients Uncontrolled on Irbesartan 150 mg Monotherapy Sanofi Completed Irbesartan Amlodipine 3 IRBAM_R_04219 NGHA-J
Effects of Ivabradine in Patients With Stable Coronary Artery Disease Without Clinical Heart Failure. A Randomised Double-blind Placebo-controlled International Multicenter Study. Servier Terminated Ivabradine 3 CL3-16257-083 KFMC
Effects of Add on Pegylated Interferon therapy in patients of Chronic hepatitis B in maintained response with ongoing nucleos(t)ide analogues ; A multicenter, prospective, randomized open label trial. KAIMRC Ongoing PEGINTERFERON ALFA-2A, RO258310 RIBAVIRIN, R0209963 3 RC14-055-R NGHA-R
View 261 - 270 From 756